참고문헌
- Nagarajan T, Marissen W, Rupprecht C. 2014. Monoclonal antibodies for the prevention of rabies: theory and clinical practice. Antibody Technol. J. 4: 1-12.
- Bourhy H, Dautry-Varsat A, Hotez PJ, Salomon J. 2010. Rabies, still neglected after 125 years of vaccination. PLoS Negl. Trop. Dis. 4: e839-e839. https://doi.org/10.1371/journal.pntd.0000839
- Knobel DL, Sarah C, Coleman PG, Fèvre EM, Meltzer MI, Miranda MEG, et al. 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 83: 360-368.
- Jaap G, Marissen WE, Weldon WC, Michael N, Hanlon CA, Rice AB, et al. 2006. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin. J. Infect. Dis. 193: 796-801. https://doi.org/10.1086/500470
- Richard F, Smith TG, Dyer JL, Xianfu W, Michael N, Rupprecht CE. 2013. Current and future tools for global canine rabies elimination. Antiviral Res. 100: 220-225. https://doi.org/10.1016/j.antiviral.2013.07.004
- Nelson AL. 2010. Antibody fragments: hope and hype. MAbs 2: 77-83. https://doi.org/10.4161/mabs.2.1.10786
- Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, et al. 1988. Single-chain antigen-binding proteins. Science 242: 423-426. https://doi.org/10.1126/science.3140379
- Weisser NE, Hall JC. 2009. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics. Biotechnol. Adv. 27: 502-520. https://doi.org/10.1016/j.biotechadv.2009.04.004
- Cheng Y, Li Z, Xi H, Gu T, Yuan R, Chen X, et al. 2015. A VL-linker-VH orientation dependent single chain variable antibody fragment against rabies virus G protein with enhanced neutralizing potency in vivo. Protein Pept. Lett. 23: 24-32. https://doi.org/10.2174/0929866522666151026122752
- Bakker A, Python C, Kissling C, Pandya P, Marissen W, Brink M, et al. 2008. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 26: 5922-5927. https://doi.org/10.1016/j.vaccine.2008.08.050
- Myun PS, Keun Jae A, Young JH, Jeon Han P, Jongsun K. 2004. Effects of novel peptides derived from the acidic tail of synuclein (ATS) on the aggregation and stability of fusion proteins. Protein Eng. Des. Sel. 17: 251-260. https://doi.org/10.1093/protein/gzh029
- Lee EN, Kim YM, Lee HJ, Sang WP, Han YJ, Lee JM, et al. 2005. Stabilizing peptide fusion for solving the stability and solubility problems of therapeutic proteins. Pharm. Res. 22: 1735-1746. https://doi.org/10.1007/s11095-005-6489-4
- Goldman ER, Brozozog-Lee PA, Dan Z, Turner KB, Walper SA, Liu JL, Anderson GP. 2014. Negative tail fusions can improve ruggedness of single domain antibodies. Protein Expr. Purif. 95: 226-232. https://doi.org/10.1016/j.pep.2014.01.003
- Duan Y, Gu TJ, Jiang CL, Yuan RS, Zhang HF, Hou HJ, et al. 2012. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency. Mol. Immunol. 51: 188-196. https://doi.org/10.1016/j.molimm.2012.03.015
- Yuan R, Chen X, Chen Y, Gu T, Xi H, Duan Y, et al. 2014. Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein. Appl. Microbiol. Biotechnol. 98: 1547-1555. https://doi.org/10.1007/s00253-013-5351-6
- Wu X, Yan X, Yang D. 2001. Affinity maturation of a human single-chain Fv by phage display. Chinese J. Microbiol. Immunol. 21: 156-159.
- Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27: 493-497.
- Duan Y, Gu T, Zhang X, Jiang C, Yuan R, Li Z, et al. 2014. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57. Mol. Immunol. 59: 136-141. https://doi.org/10.1016/j.molimm.2014.01.006
- Safar F, Vahideh A, Asghar T, Kamal V, Shiva Ahdi K, Leila R. 2014. Development trends for generation of single-chain antibody fragments. Immunopharmacol. Immunotoxicol. 36: 1-12. https://doi.org/10.3109/08923973.2013.850506
- Cai K, Wang H, Bao S, Shi J, Hou X, Gao X, et al. 2008. Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus. Microb. Infect. 10: 548-555. https://doi.org/10.1016/j.micinf.2008.02.008
- Wang DD, Su MM, Sun Y, Huang SL, Wang J, Yan WQ. 2012. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris. Protein Expr. Purif. 86: 75-81. https://doi.org/10.1016/j.pep.2012.08.015
- Liu X, Lin H, Tang Q, Li C, Yang S, Wang Z, et al. 2011. Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine. PLoS One 6: e19848. https://doi.org/10.1371/journal.pone.0019848
- Jiang H, Xie Y, Burnette A, Roach J, Giardina SL, Hecht TT, et al. 2013. Purification of clinical-grade disulfide stabilized antibody fragment variable-Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli. Appl. Microbiol. Biotechnol. 97: 621-632. https://doi.org/10.1007/s00253-012-4319-2
- Lee JH, Park DY, Lee KJ, Kim YK, So YK, Ryu JS, et al. 2013. Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody. PLoS One 8: e68772. https://doi.org/10.1371/journal.pone.0068772
- Kim Y, Lee H, Lee J, Kim H, Kim J. 2009. Expression of human interferon alpha-1 with enhanced stability via the tagging system of a stabilizing peptide. Protein Expr. Purif. 63: 140-146. https://doi.org/10.1016/j.pep.2008.09.016
- Both L, B anyard A C, V an D C, H orton D L, M a JK, Fooks AR. 2012. Passive immunity in the prevention of rabies. Lancet Infect. Dis. 12: 397-407. https://doi.org/10.1016/S1473-3099(11)70340-1
- Koprowski H, van der Scheer J, Black J. 1950. Use of hyperimmune antirabies serum concentrates in experimental rabies. Am. J. Med. 8: 412-420. https://doi.org/10.1016/0002-9343(50)90224-5
- Sikes RK, Cleary WF, Koprowski H, Wiktor TJ, Kaplan MM. 1971. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull. World Health Organ. 45: 1-11.
- Turki I, Hammami A, Kharmachi H, Mousli M. 2014. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency. Mol. Immunol. 57: 66-73. https://doi.org/10.1016/j.molimm.2013.08.009
- Todorovska A, Roovers RC, Dolezal O, Kortt AA, Hoogenboom HR, Hudson PJ. 2001. Design and application of diabodies, triabodies and tetrabodies for cancer targeting. J. Immunol. Methods 248: 47-66. https://doi.org/10.1016/S0022-1759(00)00342-2
피인용 문헌
- Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce IFN-β Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway vol.29, pp.10, 2019, https://doi.org/10.4014/jmb.1909.09017
- Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity vol.10, pp.None, 2020, https://doi.org/10.1038/s41598-020-65035-8